Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (4 quarters reported)
$61.6M in Q4 2024 → — now. Hover for any quarter.
As reported for the quarter ended September 30, 2025. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| N Nil | NaN% | Unchanged | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.
quarter ended September 30, 2025 · filed October 09, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed August 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Verona Pharma PLC | Exited | −63,499 | −$4.03M | — |
| Summit Therapeutics Inc | Exited | −124,307 | −$2.4M | — |
| Janux Therapeutics Inc | Exited | −78,500 | −$2.12M | — |
| Regeneron Pharmaceuticals | Exited | −2,600 | −$1.65M | — |
| Neurocrine Biosciences Inc | Exited | −13,612 | −$1.51M | — |
| Insmed Inc | Exited | −19,192 | −$1.46M | — |
| Soleno Therapeutics Inc | Exited | −19,858 | −$1.42M | — |
| Jazz Pharmaceuticals PLC | Exited | −9,853 | −$1.22M | — |
| Akero Therapeutics Inc | Exited | −19,925 | −$807K | — |
| Argenx Se | Exited | −1,146 | −$678K | — |
Showing the 10 largest of 20 changes.
quarter ended March 31, 2025 · filed May 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Legend Biotech Corp | Exited | −190,800 | −$6.21M | — |
| Cytokinetics Inc | Exited | −130,735 | −$6.15M | — |
| Akero Therapeutics Inc | Trimmed | −131,275 | −$5.31M | 3.9% |
| Astrazeneca PLC | Exited | −76,500 | −$5.01M | — |
| Vera Therapeutics Inc | Exited | −109,400 | −$4.63M | — |
| Verona Pharma PLC | Trimmed | −71,953 | −$4.57M | 19.3% |
| Insmed Inc | Trimmed | −50,308 | −$3.84M | 7.0% |
| Merus N V | Exited | −83,800 | −$3.52M | — |
| Cullinan Therapeutics Inc | Exited | −276,400 | −$3.37M | — |
| Cogent Biosciences Inc | Trimmed | −519,063 | −$3.11M | 0.8% |
Showing the 10 largest of 30 changes.
Loading...
